Genital Dryness, Dyspareunia, and Urinary Symptoms in Menopause When Vaginal Estrogen Has Not Worked

Genitourinary syndrome of menopause (GSM) encompasses genital dryness, burning and irritation; diminished lubrication and pain during sexual activity (dyspareunia); and urinary symptoms including urgency, dysuria, and recurrent urinary tract infections.

Previous Treatment — Goals Not Met

This protocol applies when low-dose vaginal estrogen has not provided adequate relief of vulvovaginal symptoms (dryness, dyspareunia), has not improved sexual function, and has not resolved urinary symptoms — or when vaginal estrogen is contraindicated or not desired by the patient.

Next Step: Non-Hormonal Vaginal Therapy

The approach centres on a class of non-hormonal, topically applied vaginal agents. The full protocol specifies which agent types are used, in what context, and in what order — details that go beyond this summary.

Clinical goal: relief of pain during intercourse and vaginal dryness.

Instant Access to Structured Evidence-Based Regimens

References

Genitourinary syndrome of menopause (GSM) encompasses the genital and lower urinary tract symptoms associated with postmenopausal estrogen deficiency. Symptoms may include genital dryness, burning and irritation; sexual symptoms of diminished lubrication and pain during sexual activity; and urinary symptoms of urgency, dysuria, and recurrent urinary tract infections.

Women in whom vaginal estrogens are contraindicated, or who do not wish to use vaginal estrogen, may have relief of pain during intercourse with the use of vaginal lubricants prior to intercourse. Vaginal moisturizers or vaginal hyaluronic acid therapies may help with vaginal dryness and pain with intercourse, but do not restore normal anatomy and function.

View source ↗